Expressions of E2 and E7-HPV16 proteins in pre-malignant and malignant lesions of the uterine cervix

References

• Alonso LG, Garcia-Alai MM, Nadra AD, Lapena AN, Almeida FL, Gualfetti P, Prat Gay GD (2002)High-risk (HPV16) human papillomavirus E7 oncoprotein is highly stable and extended, with conformational transitions that could explain its multiple cellular binding partners. Biochemistry 41: 10510–10518.
   PubMed Web of Science ®Google Scholar
• Arbyn M, Paraskevaidis E, Martin-Hirsch P, Prendiville W, Dillner J (2005)Clinical utility of HPV-DNA detection: triage of minor cervical lesions, follow-up of women treated for high-grade CIN: an update of pooled evidence. Gynecol. Oncol. 99: S7–S11.
   PubMed Web of Science ®Google Scholar
• Bouvard V, Matlashewski G, Gu ZM (1994)The human papillomavirus type 16 E5 gene cooperates with the E7 gene to stimulate proliferation of primary cells and increases viral gene expression. Virology 203: 73–80.
   PubMed Web of Science ®Google Scholar
• Castle PE, Schiffman M, Herrera R (2005)A prospective study of age trends in cervical human papillomavirus acquisition and persistence in Guanacaste, Costa Rica. J. Infect. Dis. 191: 1808–1816.
   PubMed Web of Science ®Google Scholar
• D’Amico M, Wu K, Fu M (2004)The inhibitor of cyclin dependent kinase 4a/alternative reading frame (INK4a/ARF) locus encoded proteins p16INK4a and p19ARF repress cyclin D1 transcription through distinct cis elements. Cancer Res. 64: 4122–4130.
   PubMed Web of Science ®Google Scholar
• Dantur K, Alonso L, Castaño E, Morelli L, Centeno-Crowley JM, Vighi S, Prat Gay G (2009)Cytosolic accumulation of HPV16 E7 oligomers supports different transformation routes for the prototypic viral oncoprotein: the amyloid-cancer connection. Int. J. Cancer 125: 1902–1911.
   PubMed Web of Science ®Google Scholar
• Desaintes C, Demeret C, Goyat S, Yaniv M, Thierry F (1997)Expression of the papillomavirus E2 protein in HeLa cells leads to apoptosis. EMBO J. 16: 504–514.
   PubMed Web of Science ®Google Scholar
• Doorbar J (2006)Molecular biology of human papillomavirus infection and cervical cancer. Clin. Sci. (Lond.) 110: 525–541.
   PubMed Web of Science ®Google Scholar
• Dreier K, Scheiden R, Lener B, Ehehalt D, Pircher H, Müller-Holzner E, Rostek U, Kaiser A, Fiedler M, Ressler S, Lechner S, Widschwendter A, Even J, Capesius C, Jansen-Dürr P, Zwerschke W(2011)Subcellular localization of the human papillomavirus 16 E7 oncoprotein in CaSki cells and its detection in cervical adenocarcinoma and adenocarcinoma in situ. Virology 409: 54–68.
   PubMed Web of Science ®Google Scholar
• Duensing S, Münger K (2004)Mini review: mechanisms of genomic instability in human cancer: insights from studies with human papillomavirus oncoproteins. Int. J. Cancer 109:157–162.
   PubMed Web of Science ®Google Scholar
• Fontaine V, Mascaux C, Weyn C, Bernis A, Celio N, Lefèvre P, Kaufman L, Garbar C (2007)Evaluation of combined general primer-mediated PCR sequencing and type-specific PCR strategies for determination of human papillomavirus genotypes in cervical cell specimens. J. Clin. Microbiol. 45: 928–934.
   PubMed Web of Science ®Google Scholar
• Franceschi S, Herrero R, Clifford GM (2006)Variations in the age-specific curves of human papillomavirus prevalence in women worldwide. Int. J. Cancer 119: 2677–2684.
   PubMed Web of Science ®Google Scholar
• Funk JO, Waga S, Harry JB, Espling E, Stillman B, Galloway DA (1997)Inhibition of CDK activity and PCNA-dependent DNA replication by p21 is blocked by interaction with the HPV-16 E7 oncoprotein. Genes Dev. 11: 2090–2100.
   PubMed Web of Science ®Google Scholar
• Holowaty P, Miller AB, Rohan T, To T (1999)Natural history of dysplasia of the uterine cervix. J. Natl. Cancer Inst. 1: 252–258.
   Web of Science ®Google Scholar
• Maufort JP, Williams SM, Pitot HC, Lambert PF (2007)Human papillomavirus 16 E5 oncogene contributes to two stages of skin carcinogenesis. Cancer Res. 67: 6106–6112.
   PubMed Web of Science ®Google Scholar
• Nasiell K, Roger V, Nasiell M (1986)Behavior of mild cervical dysplasia during long term follow-up. Obstet. Gynecol. 67: 665–669.
   PubMed Web of Science ®Google Scholar
• Negri G, Vittadello F, Romano F, Kasal A, Rivasi F, Girlando S, Mian C, Egarter-Vigl E (2004)p16INK4a expression and progression risk of low-grade intraepithelial neoplasia of the cervix uteri. Virchows Arch. 445: 616–620.
   PubMed Web of Science ®Google Scholar
• Sano T, Oyama T, Kashiwabara K, Fukuda T, Nakajima T (1998)Expression status of p16 protein is associated with human papillomavirus oncogenic potential in cervical and genital lesions. Am. J. Pathol. 153: 1741–1748.
   PubMed Web of Science ®Google Scholar
• Schwarz E, Freese UK, Gissmann L, Mayer W (1985)Structure and transcription of human papillomavirus sequences in cervical carcinoma cells. Nature 314: 111–114.
   PubMed Web of Science ®Google Scholar
• Shepherd P, Dean C (2000) Monoclonal Antibodies. Practical Approach. Oxford University Press, Oxford, London. pp. 84–120.
   Google Scholar
• Sherman L, Jackman A, Itzhaki H, Stöppler MC, Koval D, Schlegel R (1997)Inhibition of serum- and calcium-induced differentiation of human keratinocytes by HPV16 E6 oncoprotein: role of p53 inactivation. Virology 237: 296–306.
   PubMed Web of Science ®Google Scholar
• Shulzhenko N, Lyng H, Sanson GF, Morgun A (2014)Me′nage a‵ trois: an evolutionary interplay between human papillomavirus, a tumor, and a woman. Review. Trends Microbiol. 22: 345–353.
   PubMed Web of Science ®Google Scholar
• Thomas M, Banks L (1998)Inhibition of Bak-induced apoptosis by HPV-18 E6. Oncogene 17: 2943–2954.
   PubMed Web of Science ®Google Scholar
• Valle GF, Banks L (1995)The human papillomavirus (HPV)-6 and HPV-16 E5 proteins co-operate with HPV-16 E7 in the transformation of primary rodent cells. J. Gen. Virol. 76: 1239–1245.
   PubMed Web of Science ®Google Scholar
• vanBogaert L-J (2012)p16 immunocytochemistry/ immunohistochemistry: need for scoring uniformization to be clinically useful in gynecological pathology. Ann. Diagn. Pathol. 16: 422–426.
   PubMed Web of Science ®Google Scholar
• Volgareva G, Zavalishina L, Andreeva Y, Krutikova E, Golovina D, Bliev A, Spitkovsky D, Ermilova V, Kisseljov F (2004)Protein p16 as a marker of dysplastic and neoplastic alterations in cervical epithelial cells. BMC Cancer 4: 58–68.
   PubMed Web of Science ®Google Scholar
• Wentzense N, von Knebel Doeberitz M (2007)Biomarkers in cervical cancer screening. Dis. Mark. 23: 315–330.
   PubMed Web of Science ®Google Scholar
• World Medical Association (2013)Declaration of Helsinki: Ethical Principles for Medical Research Involving Human Subjects. J. Am. Med. Assoc. 310: 2191–2194.
   PubMed Web of Science ®Google Scholar
• Xue Y, Bellanger S, Zhang W, Lim D, Low J, Lunny D, Thierry F (2010)HPV16 E2 is an immediate early marker of viral infection, preceding E7 expression in precursor structures of cervical carcinoma. Cancer Res. 70: 5316–5325.
   PubMed Web of Science ®Google Scholar
• zur Hausen H (2002)Papillomaviruses and cancer: from basic studies to clinical application. Nat. Rev. Cancer 2: 342–350.
   PubMed Web of Science ®Google Scholar